INSMED INC

From the company

Insmed is a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases. Guided by science and collective expertise, it works closely with patients to understand real-world challenges and develop meaningful solutions. Its therapies include ARIKAYCE and BRINSUPRI, and its areas of innovation include gene therapy with targeted delivery, protein deimmunization, RNA end-joining, and synthetic rescue.